Cargando…

ACE2 as a potential therapeutic target for pandemic COVID-19

SARS-CoV-2 virus invades the host through angiotensin-converting enzyme 2 (ACE2) receptors by decreasing the ACE2 expression of the host. This disturbs the dynamic equilibrium between the ACE/Ang II/AT1R axis and ACE2/Ang (1–7)/Mas receptor axis. Therefore, the clinically approved drugs belonging to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chatterjee, Bhaswati, Thakur, Suman S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2020
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057484/ https://www.ncbi.nlm.nih.gov/pubmed/35515386 http://dx.doi.org/10.1039/d0ra08228g

Ejemplares similares

SARS-CoV-2 Infection Triggers Phosphorylation: Potential Target for Anti-COVID-19 Therapeutics
por: Chatterjee, Bhaswati, et al.
Publicado: (2022)

Remdesivir and Its Combination With Repurposed Drugs as COVID-19 Therapeutics
por: Chatterjee, Bhaswati, et al.
Publicado: (2022)

Investigation of post-translational modifications in type 2 diabetes
por: Chatterjee, Bhaswati, et al.
Publicado: (2018)

Cold atmospheric pressure plasma for attenuation of SARS-CoV-2 spike protein binding to ACE2 protein and the RNA deactivation
por: Khanikar, Rakesh Ruchel, et al.
Publicado: (2022)

Advances in Targeting ACE2 for Developing COVID-19 Therapeutics
por: Suvarnapathaki, Sanika, et al.
Publicado: (2022)

ACE2 : S1 RBD Interaction-Targeted Peptides and Small Molecules as Potential COVID-19 Therapeutics
por: Chitsike, Lennox, et al.
Publicado: (2021)

Immune response and possible therapeutics in COVID-19
por: Dutta, Anindya, et al.
Publicado: (2021)

Editorial: Proteomics and Its Applications in Cancer
por: Thakur, Suman S., et al.
Publicado: (2021)

Druggable targets and therapeutic development for COVID-19
por: Duan, Xiaohua, et al.
Publicado: (2022)

DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
por: Valencia, Inés, et al.
Publicado: (2020)

Off‐target ACE2 ligands: Possible therapeutic option for CoVid‐19?
por: Brogi, Simone, et al.
Publicado: (2020)

Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor
por: Al-Karmalawy, Ahmed A., et al.
Publicado: (2021)

Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19
por: Deng, Qu, et al.
Publicado: (2021)

Ig-like ACE2 protein therapeutics: A revival in development during the COVID-19 pandemic
por: Qian, Kewen, et al.
Publicado: (2020)

COVID-19 susceptibility: potential of ACE2 polymorphisms
por: Chaudhary, Mayank
Publicado: (2020)

Therapeutic potential of compounds targeting SARS-CoV-2 helicase
por: Halma, Matthew T. J., et al.
Publicado: (2022)

ACE2 Co-evolutionary Pattern Suggests Targets for Pharmaceutical Intervention in the COVID-19 Pandemic
por: Braun, Maya, et al.
Publicado: (2020)

Structure-Based Virtual Screening and Identification of Potential Inhibitors of SARS-CoV-2 S-RBD and ACE2 Interaction
por: Xiong, Jiacheng, et al.
Publicado: (2021)

ACE2, a drug target for COVID-19 treatment?
por: Liu, Yang, et al.
Publicado: (2022)

Effects of PM2.5 Exposure on the ACE/ACE2 Pathway: Possible Implication in COVID-19 Pandemic
por: Botto, Laura, et al.
Publicado: (2023)

An overview of key potential therapeutic strategies for combat in the COVID-19 battle
por: Das, Gaurav, et al.
Publicado: (2020)

Cover Feature: Simultaneous Occurrence of Nanospheres and Nanofibers Self‐Assembled from Achiral Tripeptides (ChemistryOpen 3/2019)
por: Vardhishna, Malapaka Venkata, et al.
Publicado: (2019)

Simultaneous Occurrence of Nanospheres and Nanofibers Self‐Assembled from Achiral Tripeptides
por: Vardhishna, Malapaka Venkata, et al.
Publicado: (2019)

ACE2, a promising therapeutic target for pulmonary hypertension
por: Shenoy, Vinayak, et al.
Publicado: (2011)

Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention
por: Shirbhate, Ekta, et al.
Publicado: (2021)

Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges
por: Jia, Hongpeng, et al.
Publicado: (2021)

Pharmacotherapy Based on ACE2 Targeting and COVID-19 Infection
por: Vitiello, Antonio, et al.
Publicado: (2022)

ACE2 polymorphisms as potential players in COVID-19 outcome
por: Khayat, André Salim, et al.
Publicado: (2020)

The Protective Potential Role of ACE2 against COVID-19
por: Golab, Fereshteh, et al.
Publicado: (2023)

Design of an engineered ACE2 as a novel therapeutics against COVID-19
por: Payandeh, Zahra, et al.
Publicado: (2020)

Screening of Natural Products Targeting SARS-CoV-2–ACE2 Receptor Interface – A MixMD Based HTVS Pipeline
por: Gopinath, Krishnasamy, et al.
Publicado: (2020)

Should ACE2 be given a chance in COVID-19 therapeutics: A semi-systematic review of strategies enhancing ACE2
por: Kaur, Upinder, et al.
Publicado: (2020)

Allosteric Site of ACE-2 as a Drug Target for COVID-19
por: Dutta, Kunal
Publicado: (2022)

Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting
por: Sharifkashani, Sourena, et al.
Publicado: (2020)

ACE2 as a Therapeutic Target for COVID-19; Its Role in Infectious Processes and Regulation by Modulators of the RAAS System
por: Michaud, Veronique, et al.
Publicado: (2020)

Small Molecules to Destabilize the ACE2-RBD Complex: A Molecular Dynamics Study for Potential COVID-19 Therapeutics
por: Razizadeh, Meghdad, et al.
Publicado: (2020)

Assessment of ACE1 variants and ACE1/ACE2 expression in COVID-19 patients
por: Akbari, Mohammadarian, et al.
Publicado: (2022)

Deep and Highly Sensitive Proteome Coverage by LC-MS/MS Without Prefractionation
por: Thakur, Suman S., et al.
Publicado: (2011)

Role of ACE2 in pregnancy and potential implications for COVID-19 susceptibility
por: Azinheira Nobrega Cruz, Nayara, et al.
Publicado: (2021)

Therapeutic potential of miRNAs targeting SARS-CoV-2 host cell receptor ACE2
por: Bozgeyik, Ibrahim
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6mi4i29ch1eln16uct84i55kte